Reprint

Pathogenesis and Targeted Therapy of Epilepsy

Edited by
February 2023
236 pages
  • ISBN978-3-0365-6436-4 (Hardback)
  • ISBN978-3-0365-6437-1 (PDF)

This book is a reprint of the Special Issue Pathogenesis and Targeted Therapy of Epilepsy that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

Epilepsy is one of the most prevalent neurological disorders and is characterized by recurrent seizures resulting from abnormal neuronal excitability in the central nervous system. Despite the availability of thirty-six antiseizure medications, about one-third of patients with epilepsy do not respond to the pharmacological treatment and develop a so-called “pharmaco-resistant epilepsy” or “refractory epilepsy.” Thus, there is an urgent need to develop novel, effective therapies based on novel mechanisms underlying neuronal excitability that leads to seizures. This reprint’s original research papers and review articles highlight unknown mechanisms underlying pharmaco-resistant resistant epilepsy, epileptogenesis, and seizure suppression.  

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
3CAI; GRIA1; GRIA2; intractable epilepsy; PICK1; protein kinase C; pericytes; mural cells; cytokine; blood-brain barrier; neuroinflammation; 3-phosphoinositide-dependent protein kinase-1; AKT; cyclosporin A; GluA1; GluR1; intractable epilepsy; PDK1; refractory seizure; temporal lobe epilepsy; hippocampus; 4-aminopyridine; epilepsy model; long-term potentiation; AMPA receptor; audiogenic epilepsy; rodents; fear reaction; behavior genetics; c-Fos; early gene activation; epileptogenesis; lipopolysaccharide; pentylenetetrazole; post-traumatic epilepsy; seizure susceptibility; traumatic brain injury; epilepsy; ghrelin; ghrelin receptor; epilepsy; anxiety; TRPV1 channels; neuronal activity; neuropsychiatric comorbidity; immunofluorescence; temporal lobe epilepsy; audiogenic kindling; acoustically evoked seizures; EACT; generalized tonic-clonic seizures; inherited epilepsy; TMEM1A channels; wild running seizures; astrocyte; intractable epilepsy; ML365; pharmacoresistant epilepsy; refractory seizure; cortical atrophy; hippocampal atrophy; intracerebral electrode; magnetic resonance imaging; posttraumatic epilepsy; traumatic brain injury; n/a